Company Filing History:
1 out of 35,756 
1 out of 222 
1 out of 148 Years Active: 2006-2022
Title: Gen Fujii: Innovator in Cancer Research and Display Technology
Introduction
Gen Fujii is a notable inventor based in Tokyo, Japan. He has made significant contributions to the fields of cancer research and display technology. With a total of 2 patents, his work has the potential to impact both pharmaceutical and technological industries.
Latest Patents
Fujii's latest patents include a carcinogenesis inhibitor and a method for driving liquid crystal displays. The carcinogenesis inhibitor is designed to have no side effects while providing excellent efficacy through oral administration. This innovative compound, which contains a hydantoin derivative or a pharmaceutically acceptable salt, demonstrates an ability to inhibit polyp formation and cell proliferation. It is highly regarded for its safety and effectiveness in preventing cancer occurrence and progression, as well as inhibiting recurrence and metastasis.
The second patent focuses on a method of driving an active matrix liquid crystal display using a pulse width modulation system. This method involves monitoring the temperature of the liquid crystal display panel and adjusting the gate-on voltage or data signal pulse width accordingly. By ensuring that the positive gate-on voltage is always higher than the negative gate-on voltage, the display's performance is optimized based on temperature variations.
Career Highlights
Throughout his career, Gen Fujii has worked with prominent organizations such as NEC Corporation and the National Cancer Center. His experience in these institutions has allowed him to develop groundbreaking technologies that address critical health and display challenges.
Collaborations
Fujii has collaborated with esteemed colleagues, including Michihiro Mutoh and Yurie Kurokawa. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Gen Fujii's contributions to cancer research and display technology exemplify the impact of innovative thinking in addressing complex challenges. His patents reflect a commitment to improving health outcomes and enhancing technological performance.